Maud A W Hermans (M A W Hermans)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Affordable Care Act

Clinical Practice

Magnetic Resonance

Top Venues

Clinical and experimental dermatology

Hematology (Amsterdam, Netherlands)

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Maud A W Hermans, Suzanne G M A Pasmans, Nicolette J T Arends, Thierry P P van den Bosch, Paul L A van Daele, Martijn B A van Doorn, Elise J Huisman, Antien L Mooyaart, Jeffrey Damman
Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children. Clinical and experimental dermatology 47 (9) (2022)
Maud A W Hermans, M W J Schreurs, P L A van Daele
Systemic mastocytosis with normal serum tryptase: rule or exception? Journal of the European Academy of Dermatology and Venereology : JEADV 33 (12) (2019)
Maud A W Hermans, S Q A van der Vet, P M van Hagen, Roy Gerth van Wijk, P L A van Daele
Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge study. Allergy 73 (10) (2019)
Maud A W Hermans, Benjamin Schrijver, Conny C P A van Holten-Neelen, Roy Gerth van Wijk, P Martin van Hagen, Paul L A van Daele, Willem A Dik
The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 48 (11) (2018)
C L de Mol, Maud A W Hermans, R Gerth van Wijk, P M van Hagen, P L A van Daele
Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosis. Hematology (Amsterdam, Netherlands) 22 (9) (2017)